The Chemours Company has announced the signing of strategic agreements with SRF Limited (SRF), a diversified, chemical-based multi-business conglomerate headquartered in India.
SRF is engaged in the manufacturing of industrial and specialty intermediates, including fluoropolymers.
This collaboration strengthens Chemours’ global supply chain footprint, bolsters operational flexibility, and provides access to capacity for fluoropolymers and fluoroelastomers—essential materials used across industries such as semiconductor, automotive, aerospace, chemical processing, oil and gas, and more.
With this capacity, Chemours will increase its operational flexibility and ensure a more reliable supply for customers worldwide.
By leveraging SRF’s established manufacturing excellence alongside Chemours’ advanced product technology and rigorous quality standards, the collaboration will deliver a reliable supply of high-quality products.
The agreements will supplement Chemours’ existing global operations, allowing Chemours to efficiently bring supply flexibility while requiring no upfront capital investment.
Chemours president & CEO, Denise Dignam, said this arrangement with SRF exemplifies the company’s strategy to shift its product mix to higher value applications.
SRF Limited is a diversified chemicals conglomerate with an annual turnover of $US1.7 billion. Its business portfolio spans Fluorochemicals, Specialty Chemicals, Performance Films & Foil, Technical Textiles, and Coated and Laminated Fabrics.
With a global footprint, SRF operates 13 manufacturing plants in India and one each in Thailand, South Africa, and Hungary, supported by a workforce of over 9,000 employees.
The company exports to more than 100 countries under brands such as FLORON, DYMEL and FLONIO.